These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30130779)

  • 1. Role of Skin pH in Psoriasis.
    Bigliardi PL
    Curr Probl Dermatol; 2018; 54():108-114. PubMed ID: 30130779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal barrier changes in patients with psoriasis: The role of phototherapy.
    Montero-Vilchez T; Soler-Góngora M; Martínez-López A; Ana FG; Buendía-Eisman A; Molina-Leyva A; Arias-Santiago S
    Photodermatol Photoimmunol Photomed; 2021 Jul; 37(4):285-292. PubMed ID: 33377542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF; Aphale A; Malaviya R; Sun Y; Masud S; Dombrovskiy V; Gottlieb AB
    J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis is a disease of the entire skin: non-lesional skin displays a prepsoriasis phenotype.
    Nosbaum A; Dahel K; Goujon C; Nicolas JF; Mengeaud V; Vocanson M
    Eur J Dermatol; 2021 Apr; 31(2):143-154. PubMed ID: 34001466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
    Alessandrini F; Stachowitz S; Ring J; Behrendt H
    J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.
    Westergaard M; Henningsen J; Johansen C; Rasmussen S; Svendsen ML; Jensen UB; Schrøder HD; Staels B; Iversen L; Bolund L; Kragballe K; Kristiansen K
    J Invest Dermatol; 2003 Nov; 121(5):1104-17. PubMed ID: 14708613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal expression of host response genes upon skin barrier disruption in normal skin and uninvolved skin of psoriasis and atopic dermatitis patients.
    de Koning HD; Kamsteeg M; Rodijk-Olthuis D; van Vlijmen-Willems IM; van Erp PE; Schalkwijk J; Zeeuwen PL
    J Invest Dermatol; 2011 Jan; 131(1):263-6. PubMed ID: 20861857
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of p53 protein in psoriasis.
    Baran W; Szepietowski JC; Szybejko-Machaj G
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):79-83. PubMed ID: 16200332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of lectin binding by psoriatic epidermis--dependence on pH].
    Wollina U; Hipler C; Knopf B
    Z Hautkr; 1987 Feb; 62(3):202-5. PubMed ID: 3577286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.
    Kleinpenning MM; Smits T; Ewalds E; van Erp PE; van de Kerkhof PC; Gerritsen MJ
    Br J Dermatol; 2006 Sep; 155(3):539-45. PubMed ID: 16911278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo study of 5-methoxypsoralen skin concentration after topical application.
    Colombo G; Zucchi A; Allegra F; Colombo P; Zani F; Santi P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(2):130-6. PubMed ID: 12637789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cutaneous surface parameters in psoriatic patients.
    Cannavò SP; Guarneri F; Giuffrida R; Aragona E; Guarneri C
    Skin Res Technol; 2017 Feb; 23(1):41-47. PubMed ID: 27270565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis.
    Funding AT; Johansen C; Kragballe K; Iversen L
    J Invest Dermatol; 2007 Aug; 127(8):2012-9. PubMed ID: 17429437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of epidermal subpopulations and proliferation in healthy skin, symptomless and lesional skin of spreading psoriasis.
    Körver JE; van Duijnhoven MW; Pasch MC; van Erp PE; van de Kerkhof PC
    Br J Dermatol; 2006 Oct; 155(4):688-94. PubMed ID: 16965416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH in nature, humans and skin.
    Proksch E
    J Dermatol; 2018 Sep; 45(9):1044-1052. PubMed ID: 29863755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins 60 and 70 expression of cutaneous lichen planus: comparison with normal skin and psoriasis vulgaris.
    Bayramgürler D; Ozkara SK; Apaydin R; Erçin C; Bilen N
    J Cutan Pathol; 2004 Oct; 31(9):586-94. PubMed ID: 15330989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo expression of antimicrobial peptides in atopic dermatitis.
    Clausen ML; Slotved HC; Krogfelt KA; Andersen PS; Agner T
    Exp Dermatol; 2016 Jan; 25(1):3-9. PubMed ID: 26269388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis.
    Bigliardi-Qi M; Bigliardi PL; Eberle AN; Büchner S; Rufli T
    J Invest Dermatol; 2000 Mar; 114(3):527-32. PubMed ID: 10692113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.